CIK 0001746473 · Non-accelerated filer<br>Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474272481
- Phone
- 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 90 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-05 | Curnutte John T Director | Grant or award · Common Stock (Right to Buy) | +30,000 | 30,000 | ||
| 2025-06-05 | Krognes Steve E. Director | Grant or award · Common Stock (Right to Buy) | +30,000 | 30,000 | ||
| 2025-06-05 | Cline Darren S Director | Grant or award · Common Stock (Right to Buy) | +30,000 | 30,000 | ||
| 2025-06-05 | PYOTT DAVID E I Director | Grant or award · Common Stock (Right to Buy) | +30,000 | 30,000 | ||
| 2025-06-05 | Huh Hoyoung Director | Grant or award · Common Stock (Right to Buy) | +30,000 | 30,000 | ||
| 2025-06-05 | CROWELL GAYLE A Director | Grant or award · Common Stock (Right to Buy) | +30,000 | 30,000 | ||
| 2025-01-23 | Cheung Lily Chief Human Resource Officer | Grant or award | +25,875 | 50,425 | ||
| 2025-01-23 | Cheung Lily Chief Human Resource Officer | Grant or award · Stock Option (Right to Buy) | +51,750 | 51,750 | ||
| 2025-01-23 | Ouimette Mike General Counsel & Corp. Sec'y | Grant or award | +35,000 | 105,544 | ||
| 2025-01-23 | Ouimette Mike General Counsel & Corp. Sec'y | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2025-01-23 | Hull Hans Chief Business Officer | Grant or award | +40,150 | 251,708 | ||
| 2025-01-23 | Hull Hans Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +80,300 | 80,300 | ||
| 2025-01-23 | Lefebvre Eric Chief Medical Officer | Grant or award | +45,650 | 240,224 | ||
| 2025-01-23 | Lefebvre Eric Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +91,300 | 91,300 | ||
| 2025-01-23 | Cummings Keith Lamont Chief Financial Officer | Grant or award | +56,650 | 319,258 | ||
| 2025-01-23 | Cummings Keith Lamont Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +113,300 | 113,300 | ||
| 2025-01-23 | Coulie Bernard President and CEO | Grant or award | +162,500 | 593,017 | ||
| 2025-01-23 | Coulie Bernard President and CEO | Grant or award · Stock Option (Right to Buy) | +325,000 | 325,000 | ||
| 2025-01-22 | Ouimette Mike General Counsel & Corp. Sec'y | Sale 10b5-1 | −10,230 | $10.99 | $112K | 70,544 |
| 2025-01-17 | Coulie Bernard President and CEO | Sale 10b5-1 | −52,419 | $11.20 | $587K | 430,517 |
Page 4 of 8 · 160 trades